PCO371

DRUG3 trials

Sponsors

Chugai Pharmaceutical

Conditions

HealthyHealthy VolunteersHypoparathyroidism

Phase 1

A Single Ascending Dose Study of PCO371 in Healthy Volunteers

TerminatedNCT02475616

Chugai PharmaceuticalHealthy

Start: 2015-06-30End: 2015-10-31Updated: 2015-11-20

A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism

TerminatedNCT04209179

Chugai PharmaceuticalHypoparathyroidism

Start: 2020-07-23End: 2021-05-25Updated: 2021-06-11

Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371

CompletedNCT04649216

Chugai PharmaceuticalHealthy Volunteers

Start: 2020-11-25End: 2020-12-30Updated: 2021-03-01